Opthea Boosts Leadership Ahead of Key Data Release
Company Announcements

Opthea Boosts Leadership Ahead of Key Data Release

Opthea Limited (AU:OPT) has released an update.

Opthea Limited gears up for a pivotal moment with anticipated Phase 3 data readouts in 2025, bolstering its leadership by appointing Parisa Zamiri as Chief Medical Officer, Tom Reilly as Chief Financial Officer, and Anand Sundaram as Vice President Marketing. These strategic hires aim to reinforce the company’s expertise in retinal diseases and its commercial readiness ahead of regulatory submissions. Dr. Zamiri brings a wealth of experience in ophthalmology, while Reilly and Sundaram provide strong financial leadership and marketing acumen, respectively.

For further insights into AU:OPT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskOpthea to Highlight Promising AMD Therapy at Key Events
TipRanks Australian Auto-Generated NewsdeskOpthea Limited to Present at Key November Investor Conferences
TipRanks Australian Auto-Generated NewsdeskOpthea Set to Highlight Innovations at Investor Conferences
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App